- Home
- BFRG vs EDSA Comparison
BFRG vs EDSA Comparison
Compare BFRG & EDSA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BFRG
- EDSA
- Stock Information
- Founded
- BFRG 2017
- EDSA 2015
- Country
- BFRG United States
- EDSA Canada
- Employees
- BFRG N/A
- EDSA N/A
- Industry
- BFRG Retail: Computer Software & Peripheral Equipment
- EDSA Biotechnology: Pharmaceutical Preparations
- Sector
- BFRG Technology
- EDSA Health Care
- Exchange
- BFRG Nasdaq
- EDSA Nasdaq
- Market Cap
- BFRG 16.4M
- EDSA 14.7M
- IPO Year
- BFRG 2023
- EDSA N/A
- Fundamental
- Price
- BFRG $1.51
- EDSA $2.38
- Analyst Decision
- BFRG
- EDSA Strong Buy
- Analyst Count
- BFRG 0
- EDSA 2
- Target Price
- BFRG N/A
- EDSA $13.00
- AVG Volume (30 Days)
- BFRG 204.8K
- EDSA 34.8K
- Earning Date
- BFRG 08-06-2025
- EDSA 08-08-2025
- Dividend Yield
- BFRG N/A
- EDSA N/A
- EPS Growth
- BFRG N/A
- EDSA N/A
- EPS
- BFRG N/A
- EDSA N/A
- Revenue
- BFRG N/A
- EDSA N/A
- Revenue This Year
- BFRG N/A
- EDSA N/A
- Revenue Next Year
- BFRG N/A
- EDSA N/A
- P/E Ratio
- BFRG N/A
- EDSA N/A
- Revenue Growth
- BFRG N/A
- EDSA N/A
- 52 Week Low
- BFRG $1.23
- EDSA $1.55
- 52 Week High
- BFRG $4.84
- EDSA $5.59
- Technical
- Relative Strength Index (RSI)
- BFRG 49.22
- EDSA 68.85
- Support Level
- BFRG $1.44
- EDSA $2.31
- Resistance Level
- BFRG $1.58
- EDSA $2.52
- Average True Range (ATR)
- BFRG 0.07
- EDSA 0.14
- MACD
- BFRG 0.01
- EDSA 0.03
- Stochastic Oscillator
- BFRG 46.94
- EDSA 77.27
About BFRG Bullfrog AI Holdings Inc.
Bullfrog AI Holdings Inc is a clinical-phase Biotechnology company using machine learning to advance medicine and improve human health. It uses artificial intelligence and machine learning to advance medicines for both internal and external projects. Its platform technology, named, bfLEAP, is an analytical AI/ML platform that is able to surmount the challenges of scalability and flexibility currently hindering researchers and clinicians by providing a more precise1, multi-dimensional understanding of its data.
About EDSA Edesa Biotech Inc.
Edesa Biotech Inc is a biotechnology company focused on inflammatory and immune-related diseases. It is involved in exploring novel ways to treat these diseases, including alternatives to topical steroids, which can have side effects. The company's product candidate, EB06, is an anti-CXCL10 monoclonal antibody candidate and is being developed as a therapy for vitiligo, a common autoimmune disorder that causes the skin to lose its color in patches. The other drug candidates in its product pipeline include EB05, EB07, and EB01 which are in their different phases of development.